Ovid Therapeutics Inc (OVID)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -81,036 | -60,461 | -51,980 | -64,806 | -22,414 |
| Depreciation Amortization | 307 | 255 | 142 | 80 | 57 |
| Accounts payable and accrued liabilities | 2,334 | -654 | 1,650 | 1,076 | 187 |
| Other Working Capital | 21,819 | 3,940 | -788 | 997 | 914 |
| Other Operating Activity | 4,992 | 5,830 | 5,418 | 31,183 | 3,455 |
| Operating Cash Flow | $-51,584 | $-51,091 | $-45,559 | $-31,470 | $-17,802 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 35,039 | -29,797 | -5,012 | N/A | N/A |
| PPE Investments | -127 | -57 | -34 | -39 | -30 |
| Purchase Sale Intangibles | -263 | -187 | -318 | -9 | -159 |
| Other Investing Activity | -264 | -187 | -318 | -9 | -159 |
| Investing Cash Flow | $34,648 | $-30,041 | $-5,364 | $-47 | $-189 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 47,236 | 64,253 | 286 | 69,777 | N/A |
| Other Financing Activity | -163 | 22,287 | 0 | -3,074 | -14 |
| Financing Cash Flow | $47,073 | $86,539 | $286 | $66,703 | $-14 |
| Beginning Cash Position | 41,897 | 36,490 | 87,126 | 51,940 | 69,944 |
| End Cash Position | 72,034 | 41,897 | 36,490 | 87,126 | 51,940 |
| Net Cash Flow | $30,137 | $5,408 | $-50,636 | $35,186 | $-18,005 |
| Free Cash Flow | |||||
| Operating Cash Flow | -51,584 | -51,091 | -45,559 | -31,470 | -17,802 |
| Capital Expenditure | -127 | -57 | -34 | -39 | -30 |
| Free Cash Flow | -51,711 | -51,148 | -45,592 | -31,509 | -17,832 |